A detailed history of Cx Institutional transactions in Incyte Corp stock. As of the latest transaction made, Cx Institutional holds 3,367 shares of INCY stock, worth $251,851. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,367
Previous 3,396 0.85%
Holding current value
$251,851
Previous $205,000 8.29%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$57.33 - $68.61 $1,662 - $1,989
-29 Reduced 0.85%
3,367 $222,000
Q2 2024

Jul 11, 2024

BUY
$51.18 - $63.75 $173,807 - $216,495
3,396 New
3,396 $205,000
Q4 2023

Jan 12, 2024

BUY
$52.16 - $64.19 $175,727 - $216,256
3,369 New
3,369 $211,000
Q2 2022

Aug 02, 2022

BUY
$66.18 - $83.18 $33,950 - $42,671
513 New
513 $39,000
Q4 2021

Jan 18, 2022

SELL
$63.34 - $74.11 $4,560 - $5,335
-72 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$68.67 - $84.02 $28,223 - $34,532
-411 Reduced 85.09%
72 $5,000
Q2 2021

Aug 04, 2021

BUY
$79.87 - $87.53 $10,702 - $11,729
134 Added 38.4%
483 $41,000
Q1 2021

Apr 15, 2021

BUY
$76.02 - $100.5 $5,701 - $7,537
75 Added 27.37%
349 $28,000
Q4 2020

Jan 12, 2021

BUY
$80.74 - $97.7 $4,763 - $5,764
59 Added 27.44%
274 $24,000
Q3 2020

Oct 13, 2020

BUY
$85.07 - $109.69 $5,954 - $7,678
70 Added 48.28%
215 $19,000
Q2 2020

Aug 06, 2020

BUY
$74.18 - $108.93 $4,005 - $5,882
54 Added 59.34%
145 $15,000
Q1 2020

Apr 29, 2020

SELL
$63.18 - $85.97 $11,561 - $15,732
-183 Reduced 66.79%
91 $7,000
Q4 2019

Jan 21, 2020

BUY
$73.04 - $95.72 $1,899 - $2,488
26 Added 10.48%
274 $24,000
Q3 2019

Oct 10, 2019

SELL
$72.82 - $86.52 $1,602 - $1,903
-22 Reduced 8.15%
248 $18,000
Q2 2019

Jul 17, 2019

SELL
$73.52 - $88.7 $15,365 - $18,538
-209 Reduced 43.63%
270 $23,000
Q1 2019

Apr 03, 2019

BUY
$63.56 - $88.17 $28,538 - $39,588
449 Added 1496.67%
479 $41,000
Q4 2018

Jan 14, 2019

BUY
$58.5 - $69.94 $643 - $769
11 Added 57.89%
30 $2,000
Q2 2018

Jul 12, 2018

BUY
$60.85 - $83.98 $1,156 - $1,595
19 New
19 $2,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Cx Institutional Portfolio

Follow Cx Institutional and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.